EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Pharma's Medical Affairs Bridge: From Field Insights and Stakeholder Needs to Global Scientific Strategy
Medical Affairs has evolved from being primarily a supportive and educational function to becoming a strong strategic partner earlier on Through ongoi...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Risk Management in the U.S. Pharmaceutical Industry: Supply, Manufacturing and Regulatory Resilience
US pharma risk management is the practice of identifying scoring and reducing threats to drug quality supply and compliance before they reach patients The strongest programs focus on three areas supply chain risk sourcing logistics shortages manufacturing risk quality contamination capacity and regulatory risk FDA inspections data integrity policy shifts They connect
-
Techno Trends
Lilly’s Jaypirca Gains FDA Approval for First-Line CLL/SLL Treatment
Eli Lilly and Company has received approval from the US Food and Drug Administration FDA for an additional indication for Jaypirca pirtobrutinib in adults with previously untreated chronic lymphocytic leukaemia CLL or small lymphocytic lymphoma SLL without a known p deletion The approval enables Jaypirca to be used as a firstline treatment
-
Projects
Genentech Begins US$750 Million Expansion of Oregon Manufacturing Facility
Genentech a member of the Roche Group has started construction on a US million expansion of its manufacturing facility in Hillsboro Oregon The squarefoot project will double the existing sites footprint and increase US production capacity for advanced drug delivery devices
-
Research Insights
AZP2006 in Parkinson’s disease models: A promising new neuroprotective treatment involving lysosomal homeostasis and the Progranulin/Prosaposin complex
The pathohistological hallmarks of Parkinsons disease are aggregated alphasynuclein and other aggregationprone proteins Lewy bodies Recent studies show mechanistic as well as genetic connections between lysosomal dysfunction and Parkinsons disease pathology A direct link between lysosomal function and Parkinsons disease might be the degradation of alphasynuclein within the lysosomal system
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Forgotten Biology: The Missing Link Behind Trial Outcomes
Dr. Sachin Dighe
Mr. Jayesh Chaudhary
Trial failure is not always a product failure; often, it is a population-design failure. This article explores how overlooked biological heterogeneity weakens signals, obscures efficacy and undermines...
-
2
Is Digital Transformation the Key to Pharma's Operational Excellence?
Kate Williamson
The pharmaceutical industry is undergoing a profound shift with the adoption of digital transformation, offering opportunities for operational excellence. Key aspects include data-driven decision-maki...
-
3
Mass Spectrometers: Principles, Instrumentation, Applications, and Future Perspectives
Venkata Reddy Pothireddy
Mass spectrometry is a highly sensitive analytical technique used for identifying, characterizing, and quantifying chemical and biological molecules. Its applications span pharmaceuticals, biotechnolo...
-
4
Why Are Nanotechnology Applications Important In Pharma Drug Delivery Systems?
Kate Williamson
Nanotechnology revolutionizes pharmaceutical drug delivery by addressing challenges in solubility, targeting, and sustained release. Engineered nanoparticles enhance drug efficacy, reduce side effects...
-
5
Biosimilar Market Access: Why Execution Gaps Cost Companies Hundreds of Millions
Doug Drysdale
The biosimilar market has generated over USD 56.2 billion in savings since 2015, yet many biosimilar companies systematically underperform on market access. This article examines four critical failure...
press releasesRead more...
Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
Ambry Genetics a leader in clinical genomic testing and a wholly owned subsidiary of Tempus AI Inc today announced the launch of GenomeNext and GenomeReveal a comprehensive whole genome sequencing WGS solution designed to help improve diagnosis
Enodia Therapeutics Announces Research Collaboration and License Agreement with Pfizer to Develop Sec61-Targeting Small Molecules
Enodia Therapeutics a biotechnology company developing novel smallmolecule therapies for targeted protein degradation at the point of synthesis today announced it has entered into a research collaboration and license agreement with Pfizer
OpenEvidence and Johns Hopkins Medicine Announce Landmark Collaboration to Design the Future of Medicine and Medical Education in the Age of AI
OpenEvidence the most popular AI for doctors in the United States today announced a strategic collaboration with Johns Hopkins Medicine JHM to reimagine medical education and clinical care in the age of artificial intelligence The collaboration spans two foundational pillars preparing the next gener...
Repligen completes acquisition of BioLife Solutions
Repligen Corporation NASDAQ RGEN Repligen or the Company a life sciences company focused on bioprocessing technology leadership today announced it has completed the previously announced
Events Read more...
12 - 14
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
21 - 23
Oct 2026Drug Formulation & Drug Delivery 2026
Paris, France
21 - 22
Oct 2026Advance Clinical Trials and Research 2026
Paris, France
22 - 23
Oct 2026PDA Aseptic Symposium 2026
Congress Square Nakanoshima, O...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
26 - 28
Oct 2026World Orphan Drug Congress
RAI, Amsterdam, Netherlands
27 - 28
Oct 2026PM& AC 2026
Novotel Hyderabad Convention C...
28 - 30
Oct 2026BIOPLUS-INTERPHEX Korea
COEX, Seoul
LATEST NEWSRead more...
Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
Agilent Technologies Inc announced it has entered into a definitive agreement to acquire Proscia a provider of digital pathology software for clinical and lifesciences customers in an allcash transaction valued at million in cash at closing and up to an additional
Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development
Charles River Laboratories International Inc and Magellan Stem Cells a private Australian biotech and celltherapy firm announce their collaboration to support Magellan in the development and clinical advancement of its proprietary stem cellbased therapies and regenerative medicine solutions The part...
Medicinal Genomics Launches Next-Day Pathogen Testing for Dietary Supplements
Medicinal Genomics today launched a rapid microbial testing solution for dietary supplement manufacturers that delivers nextday pathogen results compared with the three to five days typical of USP culture methods The solution includes three PathoSEEK
Americhem Opens New Clean Compounding Facility in Suzhou, China
Americhem a global leader in custom polymer solutions celebrated the opening of its new clean compounding facility in Suzhou on September The investment expands Americhems ability to support customers in China across AsiaPacific and around the world who manufacture in the region
GCCL and LabConnect Sign MOU to Expand Global Clinical Trial Collaboration
GCCL a South Koreabased leading global clinical trial central laboratory represented by CEO Kwangoo Cho announced today that it signed a Memorandum of Understanding MOU with LabConnect on October to expand global clinical trial collaboration LabConnect is a global central laboratory and clinical tr...
PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics
PacBio and TychoBio have announced a collaboration to generate fulllength RNA data for training artificial intelligence AI models that support the design of RNA therapies for rare diseases
